One Health

European Parliament Public Health Committee Backs EU–Switzerland Health and Conformity Assessment Agreements

In May 2026 the European Parliament’s Public Health Committee issued a draft opinion recommending consent to the Council decision concluding a broad package of EU–Switzerland agreements on health security and mutual recognition of product conformity assessment. While the package is still pending formal approval, this signals likely integration of Switzerland into EU health-crisis frameworks and medical-product governance, so companies active in both markets should prepare for closer alignment of surveillance, joint procurement, and conformity assessment processes.

9 May 2026, 13:28europarl.europa.euEuropean UnionSwitzerland

Germany (UBA) Publishes GerES VI Fieldwork and Data Management Report

The German Environment Agency has released the main fieldwork and data management report for its GerES VI adult environmental health survey, documenting nationwide human biomonitoring and environmental sampling carried out between May 2023 and July 2024. This strengthens the evidence base for future German and EU risk assessments on environmental chemicals and exposures, although the report itself does not introduce new regulatory obligations.

8 May 2026, 06:54umweltbundesamt.deGermany

US EPA Seeks Comment on Wolbachia-Based Mosquito Experimental Use Permit in California and Florida

In May 2026, the US Environmental Protection Agency requested public comment on an experimental use permit application from Google LLC to release Wolbachia-infected male Culex quinquefasciatus mosquitoes in California and Florida under FIFRA. If granted, this large-scale biopesticide trial would represent a significant step toward full registration of a novel vector-control technology, signalling future regulatory and operational implications for mosquito control and public health programmes.

8 May 2026, 06:45public-inspection.federalregister.govUnited States

EFSA Publishes Report on Second International Workshop on Horizon Scanning for Plant Health

EFSA and its partners have published a 2025 supporting publication summarising the Second International Workshop on Horizon Scanning for Plant Health, held in France under the EU Plant Health Regulation and focused on building a global plant-health horizon scanning community using tools like EIOS and EFSA’s PeMo. For companies and authorities dependent on plant health and biosecurity, this is a strategic signal that EU regulators are investing in more systematic, One Health-aligned early warning for plant pests, but it does not itself change legal obligations for plant protection products, emergency authorisations, or chemical controls.

3 May 2026, 09:22open.efsa.europa.euEuropean Union

France (ANSES) Takes Over Coordination of Green Data for Health (GD4H) Initiative

In April 2025, France’s ANSES assumed coordination of the Green Data for Health (GD4H) programme, a national initiative designed to link environmental datasets with health data and support integrated environmental health analysis. This strengthens France’s environmental health data infrastructure and signals a shift toward more data-driven risk assessment and potentially more stringent future policies on environmental exposures.

3 May 2026, 09:11anses.frFrance

Emilia-Romagna Approves 2026 Plan for Arbovirus Surveillance and Mosquito Control

In April 2026, the Emilia-Romagna regional government approved its 2026 plan for arbovirus surveillance and mosquito control, coordinating surveillance and mosquito-control interventions from 1 May to 31 October 2026. The plan strengthens municipal larviciding and tightly controlled adulticide use under a One Health framework, shaping how local authorities and pest-control operators plan operations and public-health risk management in the region.

EU DG SANTE One Health Workshop: Lessons From Fact-Finding Visits

DG SANTE has published a summary of a March 2026 One Health workshop that reviews lessons from fact-finding visits on serious zoonotic threats such as avian influenza and SARS-CoV-2 across multiple EU Member States. The findings highlight persistent gaps in occupational health services, worker vaccination and cross-sector coordination in high-risk animal and agrifood settings, signalling that EU authorities will focus on practical implementation of existing biological-agents-at-work rules rather than introducing new legal obligations for now.

30 Apr 2026, 15:44health.ec.europa.euEuropean Union

Rhode Island Senate Schedules Hearing On Bill S2795 Restricting Anticoagulant Rodenticides And Creating Rodent IPM Pilots

Rhode Island has scheduled a 29 April 2026 committee hearing on Bill S2795, which would restrict anticoagulant rodenticide sales and use and create municipal rodent integrated pest management pilot programmes. If the bill progresses, pest-control suppliers, retailers and municipalities in Rhode Island will face a phased shift away from anticoagulant rodenticides towards integrated pest management, requiring changes in product portfolios, contracts, and local rodent-control strategies.

30 Apr 2026, 06:37webserver.rilegislature.govUnited States

EU Amends ASF Restricted Zones in Annex I to Implementing Regulation (EU) 2023/594

The European Commission has adopted Implementing Regulation (EU) 2026/280, replacing Annex I to ASF control Regulation 2023/594 with an updated list of restricted zones I–III across affected EU Member States, in force since early February 2026. Pig producers, slaughterhouses and traders in these areas should reassess whether specific holdings have moved into stricter ASF categories and adjust animal movements, trade logistics and contingency planning to stay aligned with the revised EU zoning map.

29 Apr 2026, 18:15eur-lex.europa.euEuropean UnionGermanyEstoniaLatviaLithuaniaPolandSlovakiaCzechiaItalyGreeceCroatiaRomaniaBulgariaHungary

France Consults on Draft State Priorities and Action Plan on Endocrine Disruptors

In April 2026, France opened a public consultation on draft state priorities and a detailed national action plan to move towards zero exposure to endocrine disruptors, with comments due by 8 May 2026. This signals tighter forthcoming controls on endocrine-disrupting chemicals across products and environments, so companies should review the drafts and prepare for stronger national requirements and monitoring over the next few years.

29 Apr 2026, 12:21consultations-publiques.developpement-durable.gouv.frFrance

EMA CVMP Adopts Elemental Impurities Guideline and Mandates New Environmental Risk Assessment Work

In early 2026 EMA’s veterinary committee adopted a new guideline on managing elemental impurities in veterinary medicinal products and launched new workstreams on environmental risk assessment for parasiticides, environmental antimicrobial resistance, and emerging technologies such as mRNA vaccines. These moves tighten expectations on heavy metal control, environmental risk management, and pharmacovigilance for veterinary medicines, signalling increased scrutiny of formulation choices, environmental exposure pathways, and lifecycle risk management across animal health portfolios.

29 Apr 2026, 12:12ema.europa.euEuropean Union

EMA CVMP Opens Consultation On Draft Reflection Paper On MLS Antibiotic Use In Animals

EMA’s veterinary committee has opened consultation on a revised reflection paper reassessing the use of macrolides, lincosamides and streptogramins (MLS) in animals and their contribution to antimicrobial resistance across the One Health spectrum. The draft signals tighter future stewardship for MLS antibiotics, with likely implications for veterinary product dosing, SPC wording, environmental risk management and surveillance expectations for manufacturers, vets and livestock producers in the EU.

29 Apr 2026, 08:11ema.europa.euEuropean Union

EMA Opens Consultation on Updated MLS Use Reflection Paper for Animals in the EU

EMA has released a draft updated reflection paper on the use of macrolide, lincosamide and streptogramin antibiotics in animals in the EU, opening consultation until 31 August 2026 and highlighting their role in antimicrobial resistance and environmental contamination. The draft points to likely tighter MLS stewardship expectations on dosing, indications, surveillance and manure management, so veterinary medicine manufacturers and large livestock producers should review the proposals and consider responding with data and operational feedback.

29 Apr 2026, 08:11ema.europa.euEuropean Union

Japan Study Finds Widespread PFAS Contamination In Pet Foods

A 2026 Environmental Pollution study found widespread PFAS contamination in 100 commercial dog and cat foods sold in Japan, with several products yielding estimated exposures above human-based health reference levels. Legal analysis is already flagging this as a wake-up call for pet food brands, signalling rising regulatory and litigation risk and the need to map and manage PFAS sources in pet food ingredients and supply chains.

28 Apr 2026, 19:47sciencedirect.comJapan

European Parliament Committees Publish Amendments to Draft Regulation on Union Civil Protection Mechanism and Health Emergency Preparedness

In April 2026 the European Parliament’s environment and public health committees published extensive amendments to the draft EU Regulation on the Union Civil Protection Mechanism and health emergency preparedness, reshaping how rescEU, the ERCC and a new crisis Hub would coordinate cross-border disaster and health-crisis responses. If adopted, these changes would strengthen EU-level support for early warning, logistics and strategic stockpiling of medical countermeasures and APIs, signalling future opportunities and expectations around capacity-reservation contracts, dual-use supplies and critical health infrastructure resilience rather than immediate new duties for manufacturers.

28 Apr 2026, 11:51europarl.europa.euEuropean Union

EU PANORAMIX Study Reveals Combined Risks From Real-Life Chemical Mixtures

An EU-funded PANORAMIX study coordinated by DTU shows that real-life mixtures of man-made chemicals in blood, breast milk and other matrices can drive combined reproductive and developmental effects even when individual substances occur at levels deemed safe. These findings strengthen the case for EU regulators to incorporate mixture effects, effect-based bioassays and environment–food–human continuum profiling into chemicals legislation and risk assessment, signalling tighter scrutiny of PFAS, bisphenol A, phthalates and other persistent contaminants.

28 Apr 2026, 11:50food.dtu.dkEuropean UnionDenmark

England: APHA Introduces New General Licence for Poultry Bird Gatherings From 21 April 2026

From 21 April 2026, England’s Animal and Plant Health Agency has introduced a new poultry general licence allowing bird gatherings of galliformes and ratites under defined biosecurity conditions. This brings poultry gatherings back under the general licence regime, so show and market organisers can resume mixed-species events if they notify APHA in advance and meet strict hygiene and record-keeping duties to control avian influenza risk.

28 Apr 2026, 11:33gov.ukUnited Kingdom

Norwegian Food Safety Authority Sets 2026 Priorities for Animal By-products

Norway’s food safety authority has set 2026 priorities for animal by-product operators, focusing on clearer guidance for biogas and composting plants and better emergency preparedness with incinerators and other facilities handling carcasses and manure. Operators should expect more contact, guidance, and targeted audits in 2026 and align their waste handling, approvals, and contingency planning with these priorities.

24 Apr 2026, 08:14mattilsynet.noNorway

US FDA Issues Emergency Use Authorizations for Four Animal Drugs to Treat New World Screwworm

The US Food and Drug Administration has issued four Emergency Use Authorizations for animal drug products containing ivermectin, afoxolaner, esafoxolaner, eprinomectin, praziquantel, benzalkonium chloride, polyhexanide and cypermethrin to prevent and treat New World screwworm infestations in cattle, companion animals, birds and other captive wildlife under an existing HHS public health emergency declaration. These EUAs, effective from February and March 2026, materially expand the emergency treatment options available to veterinarians and animal health operators, who should integrate the new authorised products and their specific use conditions into contingency planning, prescribing decisions and pharmacovigilance processes.

23 Apr 2026, 12:36federalregister.govUnited States

France National Assembly Issues Environmental Health Policy Report on PFAS and Pesticides

In April 2026 the France National Assembly published a major environmental health report with 85 recommendations, including universal PFAS restriction as one family, tougher pesticide controls, expanded biosurveillance, and a unified One Health strategy with stronger funding and governance. This non-binding but politically salient report signals a clear direction of travel toward stricter upstream chemical controls, more intensive monitoring, and fuller application of polluter-pays and EU-aligned standards that could materially reshape future regulatory obligations for PFAS, pesticides, and related exposures in France.

23 Apr 2026, 09:27assemblee-nationale.frFrance